6-Bromo-2-methyl-2,3-dihydroimidazo[2,1-b]oxazol-5-amine CAS 2135332-15-7

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 6-Bromo-2-methyl-2,3-dihydroimidazo[2,1-b]oxazol-5-amine.

6-Bromo-2-methyl-2,3-dihydroimidazo[2,1-b]oxazol-5-amine (CAS 2135332-15-7) is a high-purity analytical reference standard with the molecular formula C6H8BrN3O and a molecular weight of 218.05 g/mol.

The molecular framework of 6-Bromo-2-methyl-2,3-dihydroimidazo[2,1-b]oxazol-5-amine (C6H8BrN3O) is characterized by an amide group, a hydroxyl group, an ether linkage, bromine substitution, an aromatic ring system. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures 6-Bromo-2-methyl-2,3-dihydroimidazo[2,1-b]oxazol-5-amine under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com